share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/12/20 08:00

Moomoo AI 已提取核心信息

Nukkleus announced a $10 million private placement with a New York-based family office investor on December 18, 2024. The company will issue 1,666,666 units at $6.00 per unit, with each unit comprising one common stock share and a warrant to purchase 1.5 additional shares. The warrants are exercisable at $6.00 per share with a five-year term.The proceeds will primarily fund the acquisition of Star 26 Capital Inc., which holds 95% ownership in RIMON, a key supplier of components for Israel's Iron Dome missile defense system. The offering, priced above market under Nasdaq rules, is expected to close around December 19, with Dawson James Securities serving as the exclusive placement agent.Additionally, the company granted 1,337,500 restricted stock shares to executives and directors on December 16, including 500,000 shares to Menachem Shalom and 150,000 shares to Anastasiia Kotaieva, compensating them for extended service with limited prior compensation.
Nukkleus announced a $10 million private placement with a New York-based family office investor on December 18, 2024. The company will issue 1,666,666 units at $6.00 per unit, with each unit comprising one common stock share and a warrant to purchase 1.5 additional shares. The warrants are exercisable at $6.00 per share with a five-year term.The proceeds will primarily fund the acquisition of Star 26 Capital Inc., which holds 95% ownership in RIMON, a key supplier of components for Israel's Iron Dome missile defense system. The offering, priced above market under Nasdaq rules, is expected to close around December 19, with Dawson James Securities serving as the exclusive placement agent.Additionally, the company granted 1,337,500 restricted stock shares to executives and directors on December 16, including 500,000 shares to Menachem Shalom and 150,000 shares to Anastasiia Kotaieva, compensating them for extended service with limited prior compensation.
Nukkleus于2024年12月18日宣布与一家位于纽约的家族办公室投资者达成1000万美元的定向增发。公司将以每单位6.00美元的价格发行1,666,666个单位,每个单位包括一股普通股和一个可购买1.5额外股份的Warrants。这些Warrants的行使价格为每股6.00美元,有效期为五年。募集资金主要用于收购持有RIMON95%股份的Star 26 Capital Inc.,RIMON是以色列铁穹导弹防御系统的关键元件供应商。根据纳斯达克规则,本次发行价格高于市场,预计将在12月19日左右完成,Dawson James Securities将作为独家配售代理。此外,公司于12月16日向高管和董事授予了1,337,500股限制性股票,其中包括向Menachem Shalom授予500,000股和向Anastasiia Kotaieva授予150,000股,以补偿他们在有限的先前报酬下的长期服务。
Nukkleus于2024年12月18日宣布与一家位于纽约的家族办公室投资者达成1000万美元的定向增发。公司将以每单位6.00美元的价格发行1,666,666个单位,每个单位包括一股普通股和一个可购买1.5额外股份的Warrants。这些Warrants的行使价格为每股6.00美元,有效期为五年。募集资金主要用于收购持有RIMON95%股份的Star 26 Capital Inc.,RIMON是以色列铁穹导弹防御系统的关键元件供应商。根据纳斯达克规则,本次发行价格高于市场,预计将在12月19日左右完成,Dawson James Securities将作为独家配售代理。此外,公司于12月16日向高管和董事授予了1,337,500股限制性股票,其中包括向Menachem Shalom授予500,000股和向Anastasiia Kotaieva授予150,000股,以补偿他们在有限的先前报酬下的长期服务。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息